Zymeworks Announces Participation in Upcoming Investor Conferences and Early Research & Development Day
03.10.2022 - Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, today announced that management will participate in upcoming investor conferences: Stifel 2022 Healthcare Conference. ...
Source: wallstreet-online.de